Drug Information

Drug General Information
Drug ID
D0K5DA
Former ID
DNC006020
Drug Name
N-(4-methoxybenzyl)oleamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527788]
Formula
C26H43NO2
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC=C(C=C1)OC
InChI
1S/C26H43NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-26(28)27-23-24-19-21-25(29-2)22-20-24/h10-11,19-22H,3-9,12-18,23H2,1-2H3,(H,27,28)/b11-10-
InChIKey
AABDRJHZBVPFLI-KHPPLWFESA-N
PubChem Compound ID
11502240
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [527788]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 527788Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41. Epub 2005 Oct 6.New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
Ref 527788Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41. Epub 2005 Oct 6.New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.